Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

NCT00749021 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Retinal Pigment Epithelial Detachment

Interventions

DRUG: Ranibizumab
DRUG: Ranibizumab
DRUG: Ranibizumab
DRUG: Ranibizumab

Sponsor

Clement K. Chan